Purchases and Sales Made in Q2 2022 in Revance Therapeutics, Inc. (RVNC)
This table provides information about the institutional ownership of Revance Therapeutics, Inc. (RVNC) during Q2 2022. The information is specifically focused on institutions that hold shares of Revance Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 12, 2022
Q2 2022
|
Geode Capital Management, LLC
Boston, MA |
SELL
|
- |
-99.2K- 7.43% |
$1.14M - $2.02M
|
1.24M
$3.18M
|
|
|
Aug 15, 2022
Q2 2022
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-106K- 86.25% |
$1.22M - $2.16M
|
16.9K
$43.3K
|
|
|
Aug 11, 2022
Q2 2022
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-129K- 1.9% |
$1.49M - $2.64M
|
6.69M
$17.2M
|
|
|
Aug 15, 2022
Q2 2022
|
Invesco Ltd.
Atlanta, GA |
SELL
|
- |
-155K- 71.2% |
$1.79M - $3.17M
|
62.9K
$162K
|
|
|
Aug 15, 2022
Q2 2022
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
SELL
|
- |
-181K- 23.05% |
$2.09M - $3.7M
|
606K
$1.56M
|
|
|
Aug 04, 2022
Q2 2022
|
State Of New Jersey Common Pension Fund D
|
SELL
|
- |
-200KClosed |
$2.31M - $4.08M
|
0
$0
|
|
|
Aug 09, 2022
Q2 2022
|
Cibc Asset Management Inc
Toronto, A6 |
SELL
|
- |
-471KClosed |
$5.42M - $9.6M
|
0
$0
|
|
|
Aug 02, 2022
Q2 2022
|
Jennison Associates LLC
|
SELL
|
- |
-686K- 28.08% |
$7.9M - $14M
|
1.76M
$4.51M
|
|
|
Aug 15, 2022
Q2 2022
|
Capital International Investors
Los Angeles, CA |
SELL
|
- |
-1.55MClosed |
$17.8M - $31.5M
|
0
$0
|